← Back
$SABS All transactions

SAB Biotherapeutics, Inc.

F

$ Value

Shares

988

Price

Filed

Mar 25

Insider

Name

Kropotova Alexandra

Title

CHIEF MEDICAL OFFICER

CIK

0001825323

Roles

Officer

Transaction Details

Transaction Date

2026-03-24

Code

F

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

43,296

Footnotes

Represents shares of the Issuer's common stock ("Common Stock") withheld to statisfy tax withholding requirements on the vesting of the Issuer's restricked stock units ("RSUs"). | Includes 34,553 shares of Common Stock and 8,743 shares of Common Stock which remain subject to vesting of RSUs granted under the Issuer's 2021 Equity Incentive Plan, as amended. | Each RSU represents a contingent right to receive one share of Common Stock.

Filing Info

Accession No.

0001193125-26-124231

Form Type

4

Issuer CIK

0001833214

Kropotova Alexandra's History

Date Ticker Type Value
2026-03-24 SABS F
2026-02-03 SABS A $0
2025-12-11 SABS F
2025-11-20 IBIO A $0
2025-09-19 SABS F
2025-08-26 SABS A $0

Other Insiders at SABS (90d)

Insider Bought Sold Last
Reich Samuel J
CEO
2026-02-03
Kropotova Alexandra
CHIEF MEDICAL OFFICER
2026-02-03
Sullivan Eddie Joe
PRESIDENT
2026-02-03
Bausch Christoph Lawrence
CHIEF OPERATING OFFICER
2026-02-03
To Lucy
See Remarks
2026-02-03